Literature DB >> 17653651

Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis.

Takayoshi Nishino1, Hiroyasu Oyama, Etsuko Hashimoto, Fumitake Toki, Itaru Oi, Makio Kobayashi, Keiko Shiratori.   

Abstract

BACKGROUND: The present study was undertaken to identify the clinicopathological differences between sclerosing cholangitis with autoimmune pancreatitis (SC-AIP) and primary sclerosing cholangitis (PSC).
METHODS: We retrospectively compared the clinical, cholangiographic, and liver biopsy findings between 24 cases of PSC and 24 cases of SC-AIP.
RESULTS: Patient age at the time of diagnosis was significantly lower in the PSC group than in the SC-AIP group. The peripheral blood eosinophil count was significantly higher in the PSC group than in the SC-AIP group, but the serum IgG4 level was significantly higher in the SC-AIP group. Cholangiography revealed band-like strictures, beaded appearance, and pruned-tree appearance significantly more frequently in PSC, whereas segmental strictures and strictures of the distal third of the common bile duct were significantly more common in SC-AIP. Liver biopsy revealed fibrous obliterative cholangitis only in the PSC specimens. No advanced fibrous change corresponding to Ludwig's stages 3 and 4 was observed in any of the SC-AIP specimens. IgG4-positive plasma cell infiltration of the liver was significantly more severe in SC-AIP than in PSC. Subsequent cholangiography showed no improvement in any of the PSC cases, but all SC-AIP patients responded to steroid therapy, and improvement in the strictures was observed cholangio-graphically.
CONCLUSIONS: Based on the differences between the patients' ages and blood chemistry, cholangiographic, and liver biopsy findings, SC-AIP should be differentiated from PSC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653651     DOI: 10.1007/s00535-007-2038-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  26 in total

1.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 2.  Surgical pathology of the syndrome of primary sclerosing cholangitis.

Authors:  J Ludwig
Journal:  Am J Surg Pathol       Date:  1989       Impact factor: 6.394

3.  Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas.

Authors:  K Kawaguchi; M Koike; K Tsuruta; A Okamoto; I Tabata; N Fujita
Journal:  Hum Pathol       Date:  1991-04       Impact factor: 3.466

Review 4.  Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

Authors:  K Yoshida; F Toki; T Takeuchi; S Watanabe; K Shiratori; N Hayashi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

5.  Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Hirotaka Ohara; Hitoshi Sano; Shigeru Aoki; Shinya Kobayashi; Tetsu Okamoto; Hideto Imai; Tomoyuki Nomura; Takashi Joh; Makoto Itoh
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

6.  Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy.

Authors:  Takayoshi Nishino; Fumitake Toki; Hiroyasu Oyama; Kyoko Shimizu; Keiko Shiratori
Journal:  Intern Med       Date:  2006-05-15       Impact factor: 1.271

7.  Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.

Authors:  U Broomé; R Löfberg; B Veress; L S Eriksson
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

8.  IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Yasunori Sato; Koichi Tsuneyama; Joji Haratake; Hiroshi Kurumaya; Kazuyoshi Katayanagi; Shinji Masuda; Hideki Niwa; Hideo Morimoto; Atsuo Miwa; Akio Uchiyama; Bernard C Portmann; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

9.  Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients.

Authors:  Hajime Takikawa; Yoriyuki Takamori; Atsushi Tanaka; Hiroko Kurihara; Yasuni Nakanuma
Journal:  Hepatol Res       Date:  2004-07       Impact factor: 4.288

10.  Concomitant colitis associated with primary sclerosing cholangitis.

Authors:  Naohito Uchida; Toru Ezaki; Hiroki Fukuma; Kunihiko Tsutsui; Hideki Kobara; Miho Matsuoka; Tsutomu Masaki; Seishiro Watanabe; Mitsuo Yoshida; Tsuyoshi Maeta; Fumikazu Koi; Toshiaki Nakatsu; Shigeki Kuriyama
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

View more
  37 in total

1.  Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification.

Authors:  Takahiro Nakazawa; Itaru Naitoh; Kazuki Hayashi; Fumihiro Okumura; Katsuyuki Miyabe; Michihiro Yoshida; Hiroaki Yamashita; Hirotaka Ohara; Takashi Joh
Journal:  J Gastroenterol       Date:  2011-09-23       Impact factor: 7.527

2.  IgG4-related sclerosing cholangitis: liver biopsy findings.

Authors:  Han Suk Ryu; Haeryoung Kim
Journal:  Korean J Hepatol       Date:  2011-03

3.  Is primary sclerosing cholangitis different from sclerosing cholangitis with autoimmune pancreatitis?

Authors:  Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2007-07       Impact factor: 7.527

4.  Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Itaru Naitoh; Takahiro Nakazawa; Hirotaka Ohara; Tomoaki Ando; Kazuki Hayashi; Hajime Tanaka; Fumihiro Okumura; Satoru Takahashi; Takashi Joh
Journal:  J Gastroenterol       Date:  2009-07-28       Impact factor: 7.527

5.  Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells.

Authors:  Masanori Koyabu; Kazushige Uchida; Norimasa Fukata; Takeo Kusuda; Tsukasa Ikeura; Yutaku Sakaguchi; Katsunori Yoshida; Masaaki Shimatani; Toshiro Fukui; Mitsunobu Matsushita; Yoshiko Uemura; Masaki Kaibori; Makoto Takaoka; Akiyoshi Nishio; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2009-09-18       Impact factor: 7.527

Review 6.  Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis.

Authors:  Shigeyuki Kawa; Kazuichi Okazaki; Terumi Kamisawa; Toru Shimosegawa; Masao Tanaka
Journal:  J Gastroenterol       Date:  2010-02-02       Impact factor: 7.527

Review 7.  Diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Itaru Naitoh; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Simizu; Takashi Joh
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  Resected case of eosinophilic cholangiopathy presenting with secondary sclerosing cholangitis.

Authors:  Fumihiko Miura; Takehide Asano; Hodaka Amano; Masahiro Yoshida; Naoyuki Toyota; Keita Wada; Kenichiro Kato; Tadahiro Takada; Junichi Fukushima; Fukuo Kondo; Hajime Takikawa
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

Review 9.  Endoscopic retrograde cholangiopancreatography and intraductal ultrasonography in the diagnosis of autoimmune pancreatitis and IgG4-related sclerosing cholangitis.

Authors:  Itaru Naitoh; Takahiro Nakazawa
Journal:  J Med Ultrason (2001)       Date:  2021-07-31       Impact factor: 1.314

10.  Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.

Authors:  Masanori Koyabu; Kazushige Uchida; Hideaki Miyoshi; Yutaku Sakaguchi; Toshiro Fukui; Hiroki Ikeda; Makoto Takaoka; Junko Hirohara; Akiyoshi Nishio; Yoshiko Uemura; Shinji Uemoto; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2010-01-20       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.